CN109662925A - A kind of safe and non-stimulating eye cream and preparation method thereof - Google Patents

A kind of safe and non-stimulating eye cream and preparation method thereof Download PDF

Info

Publication number
CN109662925A
CN109662925A CN201910059047.8A CN201910059047A CN109662925A CN 109662925 A CN109662925 A CN 109662925A CN 201910059047 A CN201910059047 A CN 201910059047A CN 109662925 A CN109662925 A CN 109662925A
Authority
CN
China
Prior art keywords
extract
safe
alcohol
phase
eye cream
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910059047.8A
Other languages
Chinese (zh)
Inventor
杨延辉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangzhou Daren Research And Biotechnology Co Ltd
Original Assignee
Guangzhou Daren Research And Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangzhou Daren Research And Biotechnology Co Ltd filed Critical Guangzhou Daren Research And Biotechnology Co Ltd
Priority to CN201910059047.8A priority Critical patent/CN109662925A/en
Publication of CN109662925A publication Critical patent/CN109662925A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9717Rhodophycota or Rhodophyta [red algae], e.g. Porphyra
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9706Algae
    • A61K8/9722Chlorophycota or Chlorophyta [green algae], e.g. Chlorella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59Mixtures
    • A61K2800/592Mixtures of compounds complementing their respective functions
    • A61K2800/5922At least two compounds being classified in the same subclass of A61K8/18

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a kind of safe and non-stimulating eye creams and preparation method thereof, the safe and non-stimulating eye cream includes following component: beeswax, cetostearyl alcohol, stearine, PEG-100 stearate, great Hua cocoa seeds of trees rouge, Parleam, vitamin E, ring five dimethyl silicone polymer, Butyrospermum parkii fruit rouge, ethylhexyl palmitate, carbomer, xanthan gum, hydroxyethyl cellulose, EDTA-2Na, allantoin, glycine betaine, moisturizer, hyaluronic acid, glycerol, 1, 3- butanediol, emulsifier, arginine, parahydroxyacet-ophenone, 1, 2- hexylene glycol, plant extracts, acetyl group tetrapeptide -5, green hair hawkweed extract, daisy flower extract and pure water.The present invention can effectively subtract light black eye;Moreover, each ingredient of the eye cream uses tri- grade of EWG hereinafter, natural no stimulation, safety is higher, will not increase burden to eye skin, it is free from environmental pollution.

Description

A kind of safe and non-stimulating eye cream and preparation method thereof
Technical field
The present invention relates to a kind of safe and non-stimulating eye creams and preparation method thereof.
Background technique
Currently, existing eye cream, which primarily serves moisturizing, improves the effect of microgroove.But with science and technology it is increasingly developed, people's Sleeping time also opposite postponement, thus, black eye has become people's issues that need special attention.Although and occurring being known as on the market The eye cream of black eye can be solved the problems, such as, but the eye cream fails to effectively subtract light black eye, moreover, user when in use, also holds Easily there is allergic phenomena, thus far from people's demand is met.
Summary of the invention
For overcome the deficiencies in the prior art, one of the objects of the present invention is to provide a kind of safe and non-stimulating eye cream, Light black eye can effectively be subtracted, and allergic phenomena can be greatly reduced.
The second object of the present invention is to provide the preparation method of above-mentioned safe and non-stimulating eye cream.
An object of the present invention is implemented with the following technical solutions:
A kind of safe and non-stimulating eye cream, including following component: beeswax, cetostearyl alcohol, stearine, PEG-100 are stearic Acid esters, great Hua cocoa seeds of trees rouge, arachidic alcohol, docosyl alcohol, arachidic alcohol glucoside, Parleam, vitamin E, ring five poly- two Methylsiloxane, Butyrospermum parkii fruit rouge, ethylhexyl palmitate, carbomer, xanthan gum, hydroxyethyl cellulose, EDTA-2Na, urine Bursin, glycine betaine, moisturizer, hyaluronic acid, glycerol, 1,3 butylene glycol, emulsifier, arginine, parahydroxyacet-ophenone, 1,2- oneself Glycol, plant extracts, acetyl group tetrapeptide -5, green hair hawkweed extract, daisy flower extract, amaranth, caramel colorant, β - Glucan, lavender oil, golden yellow camomile extract and pure water.
The plant extracts includes that glycyrrhiza glabra root extract, green tea leaf extract, Rosmarinus officinalis extract, centella mention Object, beauty Yi Gucao extract, Chondrus crispus extract, german chamomile flower extract, radix scutellariae root extract and polygonum cuspidate is taken to extract Object.
The glycyrrhiza glabra root extract, green tea leaf extract, Rosmarinus officinalis extract, Gotu Kola P.E, beauty Yi Gu Careless extract, Chondrus crispus extract, german chamomile flower extract, radix scutellariae root extract, Gentrin Knotweed P.E weight ratio be 7:12: 6:15:3:4:9:2:5.
The safe and non-stimulating eye cream includes following component in percentage by weight:
Beeswax 1-3%
Cetostearyl alcohol 0.5-4%
Stearine 0.5-1.5%
PEG-100 stearate 0.5-1.5%
Great Hua cocoa seeds of trees rouge 0.5-3%
Parleam 0.5-2.5%
Arachidic alcohol 0.1-0.2%
Docosyl alcohol 0.1-0.2%
Arachidic alcohol glucoside 0.2-0.3%
Vitamin E 0.05-0.15%
Ring five dimethyl silicone polymer 1-4%
Butyrospermum parkii fruit rouge 1-4%
Ethylhexyl palmitate 0.5-1.5%
Carbomer 0.1-0.3%
Xanthan gum 0.1-0.3%
Hydroxyethyl cellulose 0.05-0.15%
EDTA-2Na 0.01-0.1%
Allantoin 0.05-0.2%
Glycine betaine 0.5-2.5%
Moisturizer 1-5%
Hyaluronic acid 0.01-0.12%
Glycerol 1-6%
1,3 butylene glycol 3-14%
Emulsifier 0.5-3%
Arginine 1-3.5%
Parahydroxyacet-ophenone 1-4%
1,2- hexylene glycol 1-3.5%
Plant extracts 1.5-5%
- 5 0.5-3% of acetyl group tetrapeptide
Green hair hawkweed extract 0.1-0.6%
Daisy flower extract 0.1-0.5%
Amaranth 0.00001-0.00007%
Caramel colorant 0.0018-0.0027%
Beta glucan 0.5-1.5%
Lavender oil 0.01-0.05%
Golden yellow camomile extract 0.5-1.5%
Pure water surplus.
The safe and non-stimulating eye cream includes following component in percentage by weight:
Beeswax 2%
Cetostearyl alcohol 2%
Stearine 0.8%
PEG-100 stearate 1.2%
Great Hua cocoa seeds of trees rouge 1%
Parleam 1.5%
Arachidic alcohol 0.15%
Docosyl alcohol 0.17%
Arachidic alcohol glucoside 0.22%
Vitamin E 0.1%
Ring five dimethyl silicone polymer 2%
Butyrospermum parkii fruit rouge 2%
Ethylhexyl palmitate 1%
Carbomer 0.2%
Xanthan gum 0.2%
Hydroxyethyl cellulose 0.1%
EDTA-2Na 0.05%
Allantoin 0.1%
Glycine betaine 1.5%
Moisturizer 3%
Hyaluronic acid 0.06%
Glycerol 3%
1,3 butylene glycol 7%
Emulsifier 1.5%
Arginase 12 .2%
Parahydroxyacet-ophenone 2.24%
1,2- hexylene glycol 2.29%
Plant extracts 2.34%
Acetyl group tetrapeptide -5 1%
Green hair hawkweed extract 0.3%
Daisy flower extract 0.2%
Amaranth 0.00004%
Caramel colorant 0.0022%
Beta glucan 1%
Lavender oil 0.02%
Golden yellow camomile extract 1%
Pure water surplus.
The safe and non-stimulating eye cream includes following component in percentage by weight:
Beeswax 1.2%
Cetostearyl alcohol 0.8%
Stearine 0.8%
PEG-100 stearate 0.7%
Great Hua cocoa seeds of trees rouge 1%
Parleam 1%
Arachidic alcohol 0.16%
Docosyl alcohol 0.18%
Arachidic alcohol glucoside 0.23%
Vitamin E 0.08%
Ring five dimethyl silicone polymer 2%
Butyrospermum parkii fruit rouge 2%
Ethylhexyl palmitate 0.7%
Carbomer 0.2%
Xanthan gum 0.2%
Hydroxyethyl cellulose 0.09%
EDTA-2Na 0.05%
Allantoin 0.1%
Glycine betaine 1%
Moisturizer 1%
Hyaluronic acid 0.05%
Glycerol 2%
1,3 butylene glycol 4%
Emulsifier 0.8%
Arginine 1.5%
Parahydroxyacet-ophenone 1.5%
1,2- hexylene glycol 1.5%
Plant extracts 2%
Acetyl group tetrapeptide -5 1%
Green hair hawkweed extract 0.2%
Daisy flower extract 0.1%
Amaranth 0.00001%
Caramel colorant 0.0020%
Beta glucan 0.6%
Lavender oil 0.01%
Golden yellow camomile extract 0.5%
Pure water surplus.
The safe and non-stimulating eye cream includes following component in percentage by weight:
Beeswax 2%
Cetostearyl alcohol 2.5%
Stearine 1.2%
PEG-100 stearate 1%
Great Hua cocoa seeds of trees rouge 3%
Parleam 2%
Arachidic alcohol 0.15%
Docosyl alcohol 0.17%
Arachidic alcohol glucoside 0.22%
Vitamin E 0.12%
Ring five dimethyl silicone polymer 3%
Butyrospermum parkii fruit rouge 4%
Ethylhexyl palmitate 1.3%
Carbomer 0.3%
Xanthan gum 0.25%
Hydroxyethyl cellulose 0.1%
EDTA-2Na 0.1%
Allantoin 0.15%
Glycine betaine 2.0%
Moisturizer 4%
Hyaluronic acid 0.1%
Glycerol 3%
1,3 butylene glycol 8%
Emulsifier 2.5%
Arginase 12 .5%
Parahydroxyacet-ophenone 3%
1,2- hexylene glycol 3.5%
Plant extracts 5%
Acetyl group tetrapeptide -5 3%
Green hair hawkweed extract 0.5%
Daisy flower extract 0.5%
Amaranth 0.00006%
Caramel colorant 0.0025%
Beta glucan 1.5%
Lavender oil 0.05%
Golden yellow camomile extract 1.5%
Pure water surplus.
The moisturizer includes glyceryl acrylate and acrylic copolymer.
The second object of the present invention is implemented with the following technical solutions:
The preparation method of above-mentioned safe and non-stimulating eye cream, comprising the following steps:
A phase making step;By beeswax, cetostearyl alcohol, stearine, PEG-100 stearate, the great Hua cocoa seeds of trees Rouge, Parleam, arachidic alcohol, docosyl alcohol, arachidic alcohol glucoside, vitamin E, ring five dimethyl silicone polymer, butter fruit Tree fruit rouge and ethylhexyl palmitate mix, and heat and obtain A phase;
B phase making step: by carbomer, xanthan gum, hydroxyethyl cellulose, EDTA-2Na, allantoin, glycine betaine, moisturizer, thoroughly Bright matter acid, glycerol, 1,3-BDO and pure water are added in emulsion pot and mix, and agitating and heating, make it dissolve uniformly, obtain B phase;
AB mixes step: the A that A phase making step obtains is added to the B phase that B phase making step obtains, homogeneous 3-5min Make its emulsification uniformly, keeps the temperature 5-8min, obtain AB and mix Material;
ABCD mixes step: stirring AB mixes Material and is cooled to 70-75 DEG C, emulsifier is then added, and carry out homogeneous Processing makes its emulsification uniformly, adds arginine, and agitated uniformly obtaining ABCD mixes Material;
E phase making step: by parahydroxyacet-ophenone, 1.3 butanediols and 1,2- hexylene glycol is mixed, and is uniformly dissolved, and obtains E Phase;
F phase making step;By plant extracts, acetyl group tetrapeptide -5, green hair hawkweed extract and daisy flower extract, three-coloured amaranth Red, caramel colorant, beta glucan, lavender oil, golden yellow camomile extract are mixed, and are uniformly dissolved, and obtain F phase;
ABCDE mixes step: stirring ABCD mixes Material and is cooled to 40-45 DEG C, and E phase making step is then added and obtains To E phase, the obtained F phase of F phase making step, be uniformly mixing to obtain the safe and non-stimulating eye cream.
It, can by beeswax, cetostearyl alcohol, stearine, PEG-100 stearate, great Hua in A phase making step Can seeds of trees rouge, arachidic alcohol, docosyl alcohol, arachidic alcohol glucoside, Parleam, vitamin E, ring five dimethyl silicone polymer, After Butyrospermum parkii fruit rouge and ethylhexyl palmitate mix, it is heated to 80 DEG C -85 DEG C.
Compared with prior art, the beneficial effects of the present invention are:
A kind of safe and non-stimulating eye cream provided by the invention can reduce the deposition of melanin, promote by the way that ingredient is rationally arranged Autophagy increases cell metabolism, reduces black-eyed color and area, can effectively subtract light black eye, moreover, the low stimulation of safety, it can Greatly reduce allergic phenomena.
The preparation method of above-mentioned safe and non-stimulating eye cream provided by the invention, can be convenient to the safe and non-stimulating eye cream Production.
Specific embodiment
In the following, being described further in conjunction with specific embodiment to the present invention, it should be noted that is do not collided Under the premise of, new embodiment can be formed between various embodiments described below or between each technical characteristic in any combination.
A kind of safe and non-stimulating eye cream, including following component: beeswax, cetostearyl alcohol, stearine, PEG-100 Stearate, great Hua cocoa seeds of trees rouge, arachidic alcohol, docosyl alcohol, arachidic alcohol glucoside, Parleam, vitamin E, ring five Dimethyl silicone polymer, Butyrospermum parkii fruit rouge, ethylhexyl palmitate, carbomer, xanthan gum, hydroxyethyl cellulose, EDTA- 2Na, allantoin, glycine betaine, moisturizer, hyaluronic acid, glycerol, 1,3 butylene glycol, emulsifier, arginine, parahydroxyacet-ophenone, 1,2- hexylene glycol, plant extracts, acetyl group tetrapeptide -5, green hair hawkweed extract, daisy flower extract, amaranth, caramel Pigment, beta glucan, lavender oil, golden yellow camomile extract and pure water.
A kind of safe and non-stimulating eye cream provided by the invention utilizes great Hua cocoa seeds of trees rouge, Butyrospermum parkii fruit rouge, palm The cooperation of sour ethylhexyl, glycine betaine, moisturizer, hyaluronic acid, glycerol, lavender oil, golden yellow camomile extract can calm Skin to can promote absorption of the eye skin for nutritional ingredient, and passes through utilization for the moisture that eye skin supplement is sufficient Vitamin E, can play the role of to eye skin it is oxidation resistant, and by using acetyl group tetrapeptide -5, green hair hawkweed extract, Daisy flower extract can promote the generation of Heme oxygenase and vascular endothelial growth factor-C, so that ferroheme can be blood red It is decomposed under the action of plain oxygenase, and the synthesis of HO-1 is caused to significantly reduce, so as to reduce the deposition of pigment, and promoted certainly It bites, increases cellular energy and metabolic turnover, have facilitation for the degradation of the melanosome containing melanin, reduce black-eyed Color and area, it is seen that ground reduces black-eyed appearance, can effectively subtract light black eye, moreover, ingredient low stimulation safely, it can be significantly It reduces, even can avoid allergic phenomena.And by using tri- grade of EWG hereinafter, safety is higher, no each ingredient of the eye cream It can increase burden to eye skin, it is free from environmental pollution.
Preferably, the plant extracts include glycyrrhiza glabra root extract, green tea leaf extract, Rosmarinus officinalis extract, Gotu Kola P.E, beauty Yi Gucao (AHNFELTIA CONCINNA) extract, Chondrus crispus (CHONDRUS CRISPUS) extract, german chamomile flower extract, radix scutellariae root extract and Gentrin Knotweed P.E.And it is mentioned by the way that plant is rationally arranged The ingredient for taking object can further improve the moisturizing effects to eye skin, and can provide microelement and nutrition for eye skin Ingredient delays the aging of eye skin.
Preferably, the glycyrrhiza glabra root extract, green tea leaf extract, Rosmarinus officinalis extract, Gotu Kola P.E, beauty Beautiful Yi Gucao (AHNFELTIA CONCINNA) extract, Chondrus crispus (CHONDRUS CRISPUS) extract, Flos Chrysanthemi Extract, radix scutellariae root extract, Gentrin Knotweed P.E weight ratio be 7:12:6:15:3:49:2:5.And by the way that plant is rationally arranged The proportion of each ingredient of extract while effectively being eye skin moisturizing and provide nutritional ingredient, and can be effectively controlled into This.
Preferably, which includes following component in percentage by weight:
Beeswax 1-3%
Cetostearyl alcohol 0.5-4%
Stearine 0.5-1.5%
PEG-100 stearate 0.5-1.5%
Arachidic alcohol 0.1-0.2%
Docosyl alcohol 0.1-0.2%
Arachidic alcohol glucoside 0.2-0.3%
Great Hua cocoa seeds of trees rouge 0.5-3%
Parleam 0.5-2.5%
Vitamin E 0.05-0.15%
Ring five dimethyl silicone polymer 1-4%
Butyrospermum parkii fruit rouge 1-4%
Ethylhexyl palmitate 0.5-1.5%
Carbomer 0.1-0.3%
Xanthan gum 0.1-0.3%
Hydroxyethyl cellulose 0.05-0.15%
EDTA-2Na 0.01-0.1%
Allantoin 0.05-0.2%
Glycine betaine 0.5-2.5%
Moisturizer 1-5%
Hyaluronic acid 0.01-0.12%
Glycerol 1-6%
1,3 butylene glycol 3-14%
Emulsifier 0.5-3%
Arginine 1-3.5%
Parahydroxyacet-ophenone 1-4%
1,2- hexylene glycol 1-3.5%
Plant extracts 1.5-5%
- 5 0.5-3% of acetyl group tetrapeptide
Green hair hawkweed extract 0.1-0.6%
Daisy flower extract 0.1-0.5%
Amaranth 0.00001-0.00007%
Caramel colorant 0.0018-0.0027%
Beta glucan 0.5-1.5%
Lavender oil 0.01-0.05%
Golden yellow camomile extract 0.5-1.5%
Pure water surplus.
And the proportion of each ingredient by the way that the safe and non-stimulating eye cream is rationally arranged, while its effect can be optimized, and can Effectively control cost.
Wherein, any one existing moisturizer on the market can be used in the moisturizer in the safe and non-stimulating eye cream, and makees For preferred embodiment of the invention, the moisturizer uses glyceryl acrylate and acrylic copolymer, so that its moisturizing can be improved Effect.
Wherein, any one existing emulsifier on the market can be used in the emulsifier in the safe and non-stimulating eye cream, and makees For preferred embodiment of the invention, the emulsifier uses hydroxy-ethyl acrylate, sodium acryloyldimethyl taurate copolymers, different ten Six alkane and polysorbate -60, can effectively improve effect.
The invention also discloses the preparation methods of above-mentioned safe and non-stimulating eye cream, comprising the following steps:
A phase making step;By beeswax, cetostearyl alcohol, stearine, PEG-100 stearate, arachidic alcohol, docosyl alcohol, Arachidic alcohol glucoside, great Hua cocoa seeds of trees rouge, Parleam, vitamin E, ring five dimethyl silicone polymer, Butyrospermum parkii Fruit rouge and ethylhexyl palmitate mix, and heat and obtain A phase;
B phase making step: by carbomer, xanthan gum, hydroxyethyl cellulose, EDTA-2Na, allantoin, glycine betaine, moisturizer, thoroughly Bright matter acid, glycerol, 1,3-BDO and pure water are added in emulsion pot and mix, and agitating and heating, make it dissolve uniformly, obtain B phase;
AB mixes step: the A that A phase making step obtains is added to the B phase that B phase making step obtains, homogeneous 3-5min Make its emulsification uniformly, keeps the temperature 5-8min, obtain AB and mix Material;
ABCD mixes step: stirring AB mixes Material and is cooled to 70-75 DEG C, emulsifier is then added, and carry out homogeneous Processing makes its emulsification uniformly, adds arginine, and agitated uniformly obtaining ABCD mixes Material;
E phase making step: by parahydroxyacet-ophenone, 1.3 butanediols and 1,2- hexylene glycol is mixed, and is uniformly dissolved, and obtains E Phase;
F phase making step;By plant extracts, acetyl group tetrapeptide -5, green hair hawkweed extract and daisy flower extract, three-coloured amaranth Red, caramel colorant, beta glucan, lavender oil, golden yellow camomile extract are mixed, and are uniformly dissolved, and obtain F phase;
ABCDE mixes step: stirring ABCD mixes Material and is cooled to 40-45 DEG C, and E phase making step is then added and obtains To E phase, the obtained F phase of F phase making step, be uniformly mixing to obtain the safe and non-stimulating eye cream.
The preparation method of safe and non-stimulating eye cream provided by the invention, by the way that each step and the addition of each ingredient is rationally arranged Sequentially, it can be convenient to the production of eye cream, and the time can be greatlyd save, improved efficiency, improvement effect.
Preferably, in A phase making step, by beeswax, cetostearyl alcohol, stearine, PEG-100 stearic acid Ester, arachidic alcohol, docosyl alcohol, arachidic alcohol glucoside, great Hua cocoa seeds of trees rouge, Parleam, vitamin E, the poly- diformazan of ring five After radical siloxane, Butyrospermum parkii fruit rouge and ethylhexyl palmitate mix, it is heated to 80 DEG C -85 DEG C.In B phase making step In, by carbomer, xanthan gum, hydroxyethyl cellulose, EDTA-2Na, allantoin, glycine betaine, moisturizer, hyaluronic acid, glycerol, 1,3-BDO and pure water, which are added in emulsion pot, to be mixed, and is stirred and heated to 80 DEG C -85 DEG C.And by the way that adding for each step is rationally arranged Hot temperature can give full play to the performance of each ingredient, to optimize the effect of eye cream.
Embodiment 1
The safe and non-stimulating eye cream of the present embodiment includes following component in percentage by weight:
Beeswax 2%
Cetostearyl alcohol 2%
Stearine 0.8%
PEG-100 stearate 1.2%
Great Hua cocoa seeds of trees rouge 1%
Parleam 1.5%
Vitamin E 0.1%
Arachidic alcohol 0.1%
Docosyl alcohol 0.12%
Arachidic alcohol glucoside 0.25%
Ring five dimethyl silicone polymer 2%
Butyrospermum parkii fruit rouge 2%
Ethylhexyl palmitate 1%
Carbomer 0.2%
Xanthan gum 0.2%
Hydroxyethyl cellulose 0.1%
EDTA-2Na 0.05%
Allantoin 0.1%
Glycine betaine 1.5%
Moisturizer 3%
Hyaluronic acid 0.06%
Glycerol 3%
1,3 butylene glycol 7%
Emulsifier 1.5%
Arginase 12 .2%
Parahydroxyacet-ophenone 2.24%
1,2- hexylene glycol 2.29%
Plant extracts 2.34%
Acetyl group tetrapeptide -5 1%
Green hair hawkweed extract 0.3%
Daisy flower extract 0.2%
Amaranth 0.00004%
Caramel colorant 0.0022%
Beta glucan 1%
Lavender oil 0.02%
Golden yellow camomile extract 1%
Pure water surplus (namely 56.62776%).
And as optimal case of the invention, it, can be excellent by the way that each ingredient of safe and non-stimulating eye cream is used said ratio While changing its effect, and it can further reduce the cost.
The preparation method of the safe and non-stimulating eye cream of the present embodiment, comprising the following steps:
A phase making step;It can by the beeswax of formula ratio, cetostearyl alcohol, stearine, PEG-100 stearate, great Hua Can seeds of trees rouge, Parleam, arachidic alcohol, docosyl alcohol, arachidic alcohol glucoside, vitamin E, ring five dimethyl silicone polymer, Butyrospermum parkii fruit rouge and ethylhexyl palmitate mix, and are heated to 82 DEG C, obtain A phase;
B phase making step: by the carbomer of the 1,3 butylene glycol of 5/7 formula ratio and formula ratio, xanthan gum, hydroxyethyl cellulose, EDTA-2Na, allantoin, glycine betaine, moisturizer, hyaluronic acid, glycerol, pure water are added in emulsion pot and mix, and be heated with stirring to It 83 DEG C, makes it dissolve uniformly, obtains B phase;
AB mixes step: the A that A phase making step obtains is added to the B phase that B phase making step obtains, homogeneous 3-5min Make its emulsification uniformly, keeps the temperature 5-8min, obtain AB and mix Material;
ABCD mixes step: stirring AB mixes Material and is cooled to 70-75 DEG C, and the emulsifier of formula ratio is then added, and Carrying out homogenization makes its emulsification uniformly, adds the arginine of formula ratio, and agitated uniformly obtaining ABCD mixes Material;
E phase making step: by 2/7 formula ratio 1, parahydroxyacet-ophenone, 1.3 butanediols of 2- hexylene glycol and formula ratio are mixed, And be uniformly dissolved, obtain E phase;
F phase making step;By plant extracts, acetyl group tetrapeptide -5, green hair hawkweed extract and daisy flower extract, three-coloured amaranth Red, caramel colorant, beta glucan, lavender oil, golden yellow camomile extract are mixed, and are uniformly dissolved, and obtain F phase;
ABCDE mixes step: stirring ABCD mixes Material and is cooled to 40-45 DEG C, and E phase making step is then added and obtains To E phase, the obtained F phase of F phase making step, be uniformly mixing to obtain the safe and non-stimulating eye cream.
Embodiment 2
The safe and non-stimulating eye cream of the present embodiment includes following component in percentage by weight:
Beeswax 1.2%
Cetostearyl alcohol 0.8%
Stearine 0.8%
PEG-100 stearate 0.7%
Great Hua cocoa seeds of trees rouge 1%
Parleam 1%
Arachidic alcohol 0.12%
Docosyl alcohol 0.14%
Arachidic alcohol glucoside 0.2%
Vitamin E 0.08%
Ring five dimethyl silicone polymer 2%
Butyrospermum parkii fruit rouge 2%
Ethylhexyl palmitate 0.7%
Carbomer 0.2%
Xanthan gum 0.2%
Hydroxyethyl cellulose 0.09%
EDTA-2Na 0.05%
Allantoin 0.1%
Glycine betaine 1%
Moisturizer 1%
Hyaluronic acid 0.05%
Glycerol 2%
1,3 butylene glycol 4%
Emulsifier 0.8%
Arginine 1.5%
Parahydroxyacet-ophenone 1.5%
1,2- hexylene glycol 1.5%
Plant extracts 2%
Acetyl group tetrapeptide -5 1%
Green hair hawkweed extract 0.2%
Daisy flower extract 0.1%
Amaranth 0.00001%
Caramel colorant 0.0020%
Beta glucan 0.6%
Lavender oil 0.01%
Golden yellow camomile extract 0.5%
Pure water surplus (namely 70.85799%).
The preparation method of the safe and non-stimulating eye cream of the present embodiment, comprising the following steps:
A phase making step;By the beeswax of formula ratio, cetostearyl alcohol, stearine, PEG-100 stearate, peanut Alcohol, docosyl alcohol, arachidic alcohol glucoside, great Hua cocoa seeds of trees rouge, Parleam, vitamin E, five polydimethylsiloxanes of ring Alkane, Butyrospermum parkii fruit rouge and ethylhexyl palmitate mix, and are heated to 81 DEG C, obtain A phase;
B phase making step: by the carbomer of the 1,3 butylene glycol of 5/7 formula ratio and formula ratio, xanthan gum, hydroxyethyl cellulose, EDTA-2Na, allantoin, glycine betaine, moisturizer, hyaluronic acid, glycerol, pure water are added in emulsion pot and mix, and be heated with stirring to It 81 DEG C, makes it dissolve uniformly, obtains B phase;
AB mixes step: the A that A phase making step obtains is added to the B phase that B phase making step obtains, homogeneous 3-5min Make its emulsification uniformly, keeps the temperature 5-8min, obtain AB and mix Material;
ABCD mixes step: stirring AB mixes Material and is cooled to 70-75 DEG C, and the emulsifier of formula ratio is then added, and Carrying out homogenization makes its emulsification uniformly, adds the arginine of formula ratio, and agitated uniformly obtaining ABCD mixes Material;
E phase making step: by 2/7 formula ratio 1, parahydroxyacet-ophenone, 1.3 butanediols of 2- hexylene glycol and formula ratio are mixed, And be uniformly dissolved, obtain E phase;
F phase making step;By plant extracts, acetyl group tetrapeptide -5, green hair hawkweed extract and daisy flower extract, three-coloured amaranth Red, caramel colorant, beta glucan, lavender oil, golden yellow camomile extract are mixed, and are uniformly dissolved, and obtain F phase;
ABCDE mixes step: stirring ABCD mixes Material and is cooled to 40-45 DEG C, and E phase making step is then added and obtains To E phase, the obtained F phase of F phase making step, be uniformly mixing to obtain the safe and non-stimulating eye cream.
Embodiment 3
The safe and non-stimulating eye cream of the present embodiment includes following component in percentage by weight:
Beeswax 2%
Cetostearyl alcohol 2.5%
Stearine 1.2%
PEG-100 stearate 1%
Great Hua cocoa seeds of trees rouge 3%
Parleam 2%
Arachidic alcohol 0.15%
Docosyl alcohol 0.17%
Arachidic alcohol glucoside 0.22%
Vitamin E 0.12%
Ring five dimethyl silicone polymer 3%
Butyrospermum parkii fruit rouge 4%
Ethylhexyl palmitate 1.3%
Carbomer 0.3%
Xanthan gum 0.25%
Hydroxyethyl cellulose 0.1%
EDTA-2Na 0.1%
Allantoin 0.15%
Glycine betaine 2.0%
Moisturizer 4%
Hyaluronic acid 0.1%
Glycerol 3%
1,3 butylene glycol 8%
Emulsifier 2.5%
Arginase 12 .5%
Parahydroxyacet-ophenone 3%
1,2- hexylene glycol 3.5%
Plant extracts 5%
Acetyl group tetrapeptide -5 3%
Green hair hawkweed extract 0.5%
Daisy flower extract 0.5%
Amaranth 0.00006%
Caramel colorant 0.0025%
Beta glucan 1.5%
Lavender oil 0.05%
Golden yellow camomile extract 1.5%
Pure water surplus (namely 37.78744%).
The preparation method of the safe and non-stimulating eye cream of the present embodiment, comprising the following steps:
A phase making step;By the beeswax of formula ratio, cetostearyl alcohol, stearine, PEG-100 stearate, peanut Alcohol, docosyl alcohol, arachidic alcohol glucoside, great Hua cocoa seeds of trees rouge, Parleam, vitamin E, five polydimethylsiloxanes of ring Alkane, Butyrospermum parkii fruit rouge and ethylhexyl palmitate mix, and are heated to 85 DEG C, obtain A phase;
B phase making step: by the carbomer of the 1,3 butylene glycol of 5/7 formula ratio and formula ratio, xanthan gum, hydroxyethyl cellulose, EDTA-2Na, allantoin, glycine betaine, moisturizer, hyaluronic acid, glycerol, pure water are added in emulsion pot and mix, and be heated with stirring to It 84 DEG C, makes it dissolve uniformly, obtains B phase;
AB mixes step: the A that A phase making step obtains is added to the B phase that B phase making step obtains, homogeneous 3-5min Make its emulsification uniformly, keeps the temperature 5-8min, obtain AB and mix Material;
ABCD mixes step: stirring AB mixes Material and is cooled to 70-75 DEG C, and the emulsifier of formula ratio is then added, and Carrying out homogenization makes its emulsification uniformly, adds the arginine of formula ratio, and agitated uniformly obtaining ABCD mixes Material;
E phase making step: by 2/7 formula ratio 1, parahydroxyacet-ophenone, 1.3 butanediols of 2- hexylene glycol and formula ratio are mixed, And be uniformly dissolved, obtain E phase;
F phase making step;By plant extracts, acetyl group tetrapeptide -5, green hair hawkweed extract and daisy flower extract, three-coloured amaranth Red, caramel colorant, beta glucan, lavender oil, golden yellow camomile extract are mixed, and are uniformly dissolved, and obtain F phase;
ABCDE mixes step: stirring ABCD mixes Material and is cooled to 40-45 DEG C, and E phase making step is then added and obtains To E phase, the obtained F phase of F phase making step, be uniformly mixing to obtain the safe and non-stimulating eye cream.
Comparative example 1
The characteristics of the present embodiment: not including acetyl group tetrapeptide -5 in the safe and non-stimulating eye cream, and other are same as Example 1.
Comparative example 2
The characteristics of the present embodiment: green hair hawkweed extract, and other and 1 phase of embodiment are not included in the safe and non-stimulating eye cream Together.
Comparative example 3
The characteristics of the present embodiment: not including daisy flower extract in the safe and non-stimulating eye cream, and other are same as Example 1.
Effect assessment
1. choosing the heavier six groups of testers of black eye, every group all has 10 testers, by embodiment 1-3 and comparison The eye cream of example 1-3 is given six groups of testers respectively and is used.Every group of tester is used continuously eye cream 56 days, and early daily Evening uses.Before starting test and using after eye cream 56 days, shooting image is carried out to the eye skin of tester respectively, and Go black eye effect to evaluate eye cream according to the comparison of the shooting image of front and back, and moistening effect, assimilation effect, whether There is allergic phenomena this three then to be evaluated according to the feeling of oneself eyelet by tester, the synthesis of each group tester is commented Valence is specifically such as table 1.
1 using effect evaluation table of table
Go black eye effect Moistening effect Assimilation effect Whether allergic phenomena (if rubescent, erythema, itch occur, play rash phenomenon be allergy) is had
Embodiment 1 Well, black eye subtracts light significantly Well Well It is no, stingless excitation
Embodiment 2 Well, black eye subtracts light significantly Well Well It is no, stingless excitation
Embodiment 3 Well, black eye subtracts light significantly Well Well It is no, stingless excitation
Comparative example 1 Poor, black eye has almost no change Well Well It is no, stingless excitation
Comparative example 2 Poor, black eye has almost no change Well Well It is no, stingless excitation
Comparative example 3 Poor, black eye has almost no change Well Well It is no, stingless excitation
As known from Table 1, the eye cream of embodiment 1-3 goes black eye to work well, and after user uses 56 days, the black eye can be made big Subtract greatly light and safe, non-stimulated, does not occur allergic phenomena.And the eye cream of comparative example 1-3 goes the black eye effect poor, After tester uses 56 days, black eye has almost no change, this explanation, safe and non-stimulating eye cream of the invention must use second The combination of acyl group tetrapeptide -5, green hair hawkweed extract, daisy flower extract, three is indispensable, by utilizing acetyl group four The mutual collaboration of peptide -5, green hair hawkweed extract, daisy flower extract, to going black eye effect that can just play synergistic work With could effectively subtract light black eye.
The above embodiment is only the preferred embodiment of the present invention, and the scope of protection of the present invention is not limited thereto, The variation and replacement for any unsubstantiality that those skilled in the art is done on the basis of the present invention belong to institute of the present invention Claimed range.

Claims (10)

1. a kind of safe and non-stimulating eye cream, it is characterised in that: including following component: beeswax, cetostearyl alcohol, glycerol stearate Ester, PEG-100 stearate, great Hua cocoa seeds of trees rouge, arachidic alcohol, docosyl alcohol, arachidic alcohol glucoside, Parleam, dimension Raw element E, ring five dimethyl silicone polymer, Butyrospermum parkii fruit rouge, ethylhexyl palmitate, carbomer, xanthan gum, hydroxy ethyl fiber Element, EDTA-2Na, allantoin, glycine betaine, moisturizer, hyaluronic acid, glycerol, 1,3 butylene glycol, emulsifier, arginine, to hydroxyl Benzoylformaldoxime, 1,2- hexylene glycol, plant extracts, acetyl group tetrapeptide -5, green hair hawkweed extract, daisy flower extract, amaranth Dish is red, caramel colorant, beta glucan, lavender oil, golden yellow camomile extract and pure water.
2. safe and non-stimulating eye cream as described in claim 1, it is characterised in that: the plant extracts includes glycyrrhiza glabra root Extract, green tea leaf extract, Rosmarinus officinalis extract, Gotu Kola P.E, beauty Yi Gucao extract, Chondrus crispus extract Object, german chamomile flower extract, radix scutellariae root extract and Gentrin Knotweed P.E.
3. safe and non-stimulating eye cream as claimed in claim 2, it is characterised in that: the glycyrrhiza glabra root extract, green tea Extract, Rosmarinus officinalis extract, Gotu Kola P.E, beauty Yi Gucao extract, Chondrus crispus extract, Flos Chrysanthemi extract Object, radix scutellariae root extract, Gentrin Knotweed P.E weight ratio be 7:12:6:15:3:4:9:2:5.
4. safe and non-stimulating eye cream as described in claim 1, it is characterised in that: the safe and non-stimulating eye cream includes according to weight The following component of percentages:
Beeswax 1-3%
Cetostearyl alcohol 0.5-4%
Stearine 0.5-1.5%
PEG-100 stearate 0.5-1.5%
Great Hua cocoa seeds of trees rouge 0.5-3%
Parleam 0.5-2.5%
Arachidic alcohol 0.1-0.2%
Docosyl alcohol 0.1-0.2%
Arachidic alcohol glucoside 0.2-0.3%
Vitamin E 0.05-0.15%
Ring five dimethyl silicone polymer 1-4%
Butyrospermum parkii fruit rouge 1-4%
Ethylhexyl palmitate 0.5-1.5%
Carbomer 0.1-0.3%
Xanthan gum 0.1-0.3%
Hydroxyethyl cellulose 0.05-0.15%
EDTA-2Na 0.01-0.1%
Allantoin 0.05-0.2%
Glycine betaine 0.5-2.5%
Moisturizer 1-5%
Hyaluronic acid 0.01-0.12%
Glycerol 1-6%
1,3 butylene glycol 3-14%
Emulsifier 0.5-3%
Arginine 1-3.5%
Parahydroxyacet-ophenone 1-4%
1,2- hexylene glycol 1-3.5%
Plant extracts 1.5-5%
- 5 0.5-3% of acetyl group tetrapeptide
Green hair hawkweed extract 0.1-0.6%
Daisy flower extract 0.1-0.5%
Amaranth 0.00001-0.00007%
Caramel colorant 0.0018-0.0027%
Beta glucan 0.5-1.5%
Lavender oil 0.01-0.05%
Golden yellow camomile extract 0.5-1.5%
Pure water surplus.
5. safe and non-stimulating eye cream as claimed in claim 4, it is characterised in that: the safe and non-stimulating eye cream includes according to weight The following component of percentages:
Beeswax 2%
Cetostearyl alcohol 2%
Stearine 0.8%
PEG-100 stearate 1.2%
Great Hua cocoa seeds of trees rouge 1%
Parleam 1.5%
Arachidic alcohol 0.15%
Docosyl alcohol 0.17%
Arachidic alcohol glucoside 0.22%
Vitamin E 0.1%
Ring five dimethyl silicone polymer 2%
Butyrospermum parkii fruit rouge 2%
Ethylhexyl palmitate 1%
Carbomer 0.2%
Xanthan gum 0.2%
Hydroxyethyl cellulose 0.1%
EDTA-2Na 0.05%
Allantoin 0.1%
Glycine betaine 1.5%
Moisturizer 3%
Hyaluronic acid 0.06%
Glycerol 3%
1,3 butylene glycol 7%
Emulsifier 1.5%
Arginase 12 .2%
Parahydroxyacet-ophenone 2.24%
1,2- hexylene glycol 2.29%
Plant extracts 2.34%
Acetyl group tetrapeptide -5 1%
Green hair hawkweed extract 0.3%
Daisy flower extract 0.2%
Amaranth 0.00004%
Caramel colorant 0.0022%
Beta glucan 1%
Lavender oil 0.02%
Golden yellow camomile extract 1%
Pure water surplus.
6. safe and non-stimulating eye cream as claimed in claim 4, it is characterised in that: the safe and non-stimulating eye cream includes according to weight The following component of percentages:
Beeswax 1.2%
Cetostearyl alcohol 0.8%
Stearine 0.8%
PEG-100 stearate 0.7%
Great Hua cocoa seeds of trees rouge 1%
Parleam 1%
Arachidic alcohol 0.16%
Docosyl alcohol 0.2%
Arachidic alcohol glucoside 0.2%
Vitamin E 0.08%
Ring five dimethyl silicone polymer 2%
Butyrospermum parkii fruit rouge 2%
Ethylhexyl palmitate 0.7%
Carbomer 0.2%
Xanthan gum 0.2%
Hydroxyethyl cellulose 0.09%
EDTA-2Na 0.05%
Allantoin 0.1%
Glycine betaine 1%
Moisturizer 1%
Hyaluronic acid 0.05%
Glycerol 2%
1,3 butylene glycol 4%
Emulsifier 0.8%
Arginine 1.5%
Parahydroxyacet-ophenone 1.5%
1,2- hexylene glycol 1.5%
Plant extracts 2%
Acetyl group tetrapeptide -5 1%
Green hair hawkweed extract 0.2%
Daisy flower extract 0.1%
Amaranth 0.00001%
Caramel colorant 0.0020%
Beta glucan 0.6%
Lavender oil 0.01%
Golden yellow camomile extract 0.5%
Pure water surplus.
7. safe and non-stimulating eye cream as claimed in claim 4, it is characterised in that: the safe and non-stimulating eye cream includes according to weight The following component of percentages:
Beeswax 2%
Cetostearyl alcohol 2.5%
Stearine 1.2%
PEG-100 stearate 1%
Great Hua cocoa seeds of trees rouge 3%
Parleam 2%
Arachidic alcohol 0.1%
Docosyl alcohol 0.1%
Arachidic alcohol glucoside 0.25%
Vitamin E 0.12%
Ring five dimethyl silicone polymer 3%
Butyrospermum parkii fruit rouge 4%
Ethylhexyl palmitate 1.3%
Carbomer 0.3%
Xanthan gum 0.25%
Hydroxyethyl cellulose 0.1%
EDTA-2Na 0.1%
Allantoin 0.15%
Glycine betaine 2.0%
Moisturizer 4%
Hyaluronic acid 0.1%
Glycerol 3%
1,3 butylene glycol 8%
Emulsifier 2.5%
Arginase 12 .5%
Parahydroxyacet-ophenone 3%
1,2- hexylene glycol 3.5%
Plant extracts 5%
Acetyl group tetrapeptide -5 3%
Green hair hawkweed extract 0.5%
Daisy flower extract 0.5%
Amaranth 0.00006%
Caramel colorant 0.0025%
Beta glucan 1.5%
Lavender oil 0.05%
Golden yellow camomile extract 1.5%
Pure water surplus.
8. safe and non-stimulating eye cream as described in claim 1, it is characterised in that: the moisturizer include glyceryl acrylate and Acrylic copolymer.
9. the preparation method of the described in any item safe and non-stimulating eye creams of claim 1-8, it is characterised in that: including following step It is rapid:
A phase making step;By beeswax, cetostearyl alcohol, stearine, PEG-100 stearate, the great Hua cocoa seeds of trees Rouge, arachidic alcohol, docosyl alcohol, arachidic alcohol glucoside, Parleam, vitamin E, ring five dimethyl silicone polymer, butter fruit Tree fruit rouge and ethylhexyl palmitate mix, and heat and obtain A phase;
B phase making step: by carbomer, xanthan gum, hydroxyethyl cellulose, EDTA-2Na, allantoin, glycine betaine, moisturizer, thoroughly Bright matter acid, glycerol, 1,3-BDO and pure water are added in emulsion pot and mix, and agitating and heating, make it dissolve uniformly, obtain B phase;
AB mixes step: the A that A phase making step obtains is added to the B phase that B phase making step obtains, homogeneous 3-5min Make its emulsification uniformly, keeps the temperature 5-8min, obtain AB and mix Material;
ABCD mixes step: stirring AB mixes Material and is cooled to 70-75 DEG C, emulsifier is then added, and carry out homogeneous Processing makes its emulsification uniformly, adds arginine, and agitated uniformly obtaining ABCD mixes Material;
E phase making step: by parahydroxyacet-ophenone, 1.3 butanediols and 1,2- hexylene glycol is mixed, and is uniformly dissolved, and obtains E Phase;
F phase making step;By plant extracts, acetyl group tetrapeptide -5, green hair hawkweed extract and daisy flower extract, three-coloured amaranth Red, caramel colorant, beta glucan, lavender oil, golden yellow camomile extract are mixed, and are uniformly dissolved, and obtain F phase;
ABCDE mixes step: stirring ABCD mixes Material and is cooled to 40-45 DEG C, and E phase making step is then added and obtains To E phase, the obtained F phase of F phase making step, be uniformly mixing to obtain the safe and non-stimulating eye cream.
10. the preparation method of safe and non-stimulating eye cream as claimed in claim 9, it is characterised in that: in A phase making step, By beeswax, cetostearyl alcohol, stearine, PEG-100 stearate, great Hua cocoa seeds of trees rouge, Parleam, flower Raw alcohol, docosyl alcohol, arachidic alcohol glucoside, vitamin E, ring five dimethyl silicone polymer, Butyrospermum parkii fruit rouge and palm acid ethyl After own ester mixes, it is heated to 80 DEG C -85 DEG C.
CN201910059047.8A 2019-01-22 2019-01-22 A kind of safe and non-stimulating eye cream and preparation method thereof Pending CN109662925A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910059047.8A CN109662925A (en) 2019-01-22 2019-01-22 A kind of safe and non-stimulating eye cream and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910059047.8A CN109662925A (en) 2019-01-22 2019-01-22 A kind of safe and non-stimulating eye cream and preparation method thereof

Publications (1)

Publication Number Publication Date
CN109662925A true CN109662925A (en) 2019-04-23

Family

ID=66150753

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910059047.8A Pending CN109662925A (en) 2019-01-22 2019-01-22 A kind of safe and non-stimulating eye cream and preparation method thereof

Country Status (1)

Country Link
CN (1) CN109662925A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109966186A (en) * 2019-05-15 2019-07-05 伊犁弥玥泉生物科技有限公司 A kind of moisturizing maintenance composition of releiving of the hot spring containing mineral
CN111053721A (en) * 2020-01-03 2020-04-24 深圳市仙迪化妆品股份有限公司 Silky glowing eye cream and preparation method thereof
CN111281830A (en) * 2020-02-26 2020-06-16 伊诗芮丝生物科技(上海)有限公司 Preparation process and formula of repair eye cream
CN112516054A (en) * 2020-12-30 2021-03-19 福建臻昕美生物科技有限公司 Tea polyphenol protein cream for repairing, moisturizing and strengthening skin and production process thereof
CN113041201A (en) * 2021-04-13 2021-06-29 东晟源研究院(广州)有限公司 Wrinkle-smoothing eye cream
CN114246821A (en) * 2022-01-11 2022-03-29 仲恺农业工程学院 Moisturizing eye cream and preparation method thereof
CN115282078B (en) * 2022-08-29 2023-09-01 广东丸美生物技术股份有限公司 Full-effect eye cream and preparation method thereof
WO2023225551A1 (en) * 2022-05-18 2023-11-23 Glaukos Corporation Novel applications of zwitterions in ophthalmic topical cream compositions and preparations

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008151890A1 (en) * 2007-06-11 2008-12-18 Chanel Parfums Beaute Use of active agents for stimulating the expression of fn3k and/or fn3k rp for combating ageing of the skin
CN105997841A (en) * 2016-08-08 2016-10-12 黄美风 Beauty maintenance eye cream and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008151890A1 (en) * 2007-06-11 2008-12-18 Chanel Parfums Beaute Use of active agents for stimulating the expression of fn3k and/or fn3k rp for combating ageing of the skin
CN105997841A (en) * 2016-08-08 2016-10-12 黄美风 Beauty maintenance eye cream and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
广州达人研选生物科技有限公司: "枫丹白露光韵活能振动眼霜", 《国产非特殊用途化妆品备案网服务平台》 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109966186A (en) * 2019-05-15 2019-07-05 伊犁弥玥泉生物科技有限公司 A kind of moisturizing maintenance composition of releiving of the hot spring containing mineral
CN109966186B (en) * 2019-05-15 2022-04-26 伊犁弥玥泉生物科技有限公司 Soothing and moisturizing repairing composition containing mineral hot spring
CN111053721A (en) * 2020-01-03 2020-04-24 深圳市仙迪化妆品股份有限公司 Silky glowing eye cream and preparation method thereof
CN111053721B (en) * 2020-01-03 2022-02-15 深圳市仙迪化妆品股份有限公司 Silky glowing eye cream and preparation method thereof
CN111281830A (en) * 2020-02-26 2020-06-16 伊诗芮丝生物科技(上海)有限公司 Preparation process and formula of repair eye cream
CN112516054A (en) * 2020-12-30 2021-03-19 福建臻昕美生物科技有限公司 Tea polyphenol protein cream for repairing, moisturizing and strengthening skin and production process thereof
CN113041201A (en) * 2021-04-13 2021-06-29 东晟源研究院(广州)有限公司 Wrinkle-smoothing eye cream
CN114246821A (en) * 2022-01-11 2022-03-29 仲恺农业工程学院 Moisturizing eye cream and preparation method thereof
CN114246821B (en) * 2022-01-11 2023-05-23 仲恺农业工程学院 Moisturizing eye cream and preparation method thereof
WO2023225551A1 (en) * 2022-05-18 2023-11-23 Glaukos Corporation Novel applications of zwitterions in ophthalmic topical cream compositions and preparations
CN115282078B (en) * 2022-08-29 2023-09-01 广东丸美生物技术股份有限公司 Full-effect eye cream and preparation method thereof

Similar Documents

Publication Publication Date Title
CN109662925A (en) A kind of safe and non-stimulating eye cream and preparation method thereof
CN101889966B (en) Preparation method of tea oil anti-cracking cream composition and product thereof
CN103263372B (en) Natural flower petal and cosmetic adopting same
CN101199462B (en) Scouring bath product suited for skin trait of infant 7 to 12 months old and process for preparing same
CN105796424A (en) Acne-removing composition and application thereof to cosmetics
CN103340817A (en) Radix puerariae whitening facial mask
CN105816389A (en) Cosmetic composite with breast maintenance effect
CN106176324B (en) A kind of Whitening sunscreen cream and preparation method thereof containing Noni fruit essential oil
CN105342973A (en) Tea polyphenol sun cream and preparation method thereof
CN108653080B (en) Tea bran shampoo and preparation method thereof
CN103385841A (en) Whitening and skin-activation Chinese herbal medicine mask and preparation method thereof
CN105326696A (en) Natural plant antioxidant essence milk and preparation method thereof
CN102058513B (en) Chinese herbal medicine crude solution and cosmetic containing same
CN109464354B (en) Skin care composition with effects of reducing subcutaneous fat content and improving skin firmness
CN101032456B (en) Hairdressing combination made of natural vegetable and preparing method thereof
CN107157862A (en) A kind of cosmetics and preparation method with replenishing water and preserving moisture effect
CN109674725A (en) A kind of dendrobium candidum hand lotion
CN104546589A (en) Skin moisturizer with components from natural food and application of skin moisturizer
CN113384502A (en) Moisturizing emulsion and preparation method thereof
CN109223664A (en) A kind of skin cream and preparation method preventing and treating eczema, bite by mosquitos
CN105963178A (en) Cosmetic composition with function of removing red blood streaks
CN106727017A (en) A kind of natural face cream containing filiale polysaccharide
CN115737512B (en) Essence with hair loss prevention and hair growth functions and preparation method thereof
CN106361643A (en) Eupatorium adenophora spreng. skin-whitening mask
CN112972347A (en) Plant extract hair care essential oil

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190423